XTL Biopharmaceuticals Announces Pricing of $4.0 Million Registered Direct Offering

Go back to XTL Biopharmaceuticals Announces Pricing of $4.0 Million Registered Direct Offering
SPDR S&P TELECOM ETF (NYSE: XTL) Delayed: 210.17 +3.93 (1.91%)
Previous Close $206.24    52 Week High $67.19 
Open $207.70    52 Week Low $47.03 
Day High $211.28    P/E N/A 
Day Low $207.70    EPS $0.00 
Volume 35,727       

SPDR S&P TELECOM ETF (NYSE: XTL) Delayed: 210.17 +3.93 (1.91%)
Previous Close $206.24    52 Week High $67.19 
Open $207.70    52 Week Low $47.03 
Day High $211.28    P/E N/A 
Day Low $207.70    EPS $0.00 
Volume 35,727       

XTL BIOPHARM SP ADR (NASDAQ: XTLB) Delayed: 2.56 +0.04 (1.59%)
Previous Close $2.52    52 Week High $1.75 
Open $2.47    52 Week Low $0.64 
Day High $2.56    P/E N/A 
Day Low $2.47    EPS $0.00 
Volume 1,601       

XTL Biopharmaceuticals Ltd. American Depositary Shares (AMEX: XTLBY) Delayed: 5.58 --0 (-0%)
Previous Close $5.58    52 Week High $7.80 
Open $5.58    52 Week Low $0.51 
Day High $5.58    P/E N/A 
Day Low $5.58    EPS $0.00 
Volume 505,536